Switzerland’s drug authority has granted approval for the first malaria medication specifically designed for infants and ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Kenya is among eight African countries that participated in clinical trials for a newly approved malaria treatment, ...

Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

Switzerland rsquo;s recent approval of Coartem Baby, the first antimalarial treatment specifically designed for newborns and ...

The first malaria treatment specifically developed for newborn babies and young infants has been approved for use.   The approval, by Switzerland’s medical agency Swissmedic, of Coartem Baby ...